Fourteen patients were revised to a diagnosis of DLBCL or HGBL, due to disagreement between central and local pathology review (n = 9; 23.7%), administrative errors (n = 2) or absence of fluorescence in situ hybridisation to confirm MYC‐R (n = 3). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.